Additional sources of ROS in NAFLD include CYP2E1 induction by free fatty acids [4, 44], mitochondrial dysfunction, and increased NADPH oxidase activity [44, 45], as well as accumulation of ceramides within the hepatocytes [46]. Here, FMO5 is linked to metabolic dysfunction-associated steatotic liver disease.